Latest News for: scd1
Edit
Galmed Unveils Novel Pharmacodynamic Blood Markers for Aramchol, the Most Clinically Advanced SCD1 Inhibitor
PR Newswire 15 Apr 2025
... oncology indications, today announces the unveiling of novel pharmacodynamic (PD) blood markers for its lead compound, Aramchol, the industry's most clinically advanced SCD1 inhibitor.
Edit
Galmed Unveils Novel Pharmacodynamic Blood Markers for Aramchol, the Most Clinically Advanced SCD1 Inhibitor (Form 6-K) (Galmed Pharmaceuticals Ltd)
Public Technologies 15 Apr 2025
Edit
Galmed Announces Positive Part 1 Results from the AM-001 Study of Aramchol Meglumine, an Enhanced Formulation of the Most Clinically Advanced SCD1 Inhibitor (Form 6-K) (Galmed Pharmaceuticals Ltd)
Public Technologies 10 Apr 2025
). Galmed Announces Positive Part 1 Results from the AM-001 Study of Aramchol Meglumine, an Enhanced Formulation of the Most Clinically Advanced SCD1 Inhibitor ... TEL AVIV, Israel, April 10, 2025 /PRNewswire/ - Galmed Pharmaceuticals Ltd. (Nasdaq ... (noodl.
- 1